Last updated:
ID:
90910
Start date:
20 September 2022
Project status:
Current
Principal investigator:
Dr Samuel O. Antwi
Lead institution:
Mayo Clinic, United States of America

Genes involved in metabolism plays plausible roles in liver cancer development in persons with fatty liver disease. Inherited genetic predisposition to other genes has been associated with risk of multiple cancers, including pancreatic, ovarian, breast, and gastric cancer. The primary aim of this project is to investigate the association between inherited genetic variants in genes involved in metabolism and the risk of liver cancer development in persons with fatty liver disease. Our secondary aim is to investigate the association between previously established cancer susceptibility genes and the risk of liver cancer development. We expect findings from this research to improve approaches for risk prevention and early detection of liver cancer.